Etzioni R - Search Results

1

Models in the development of clinical practice guidelines.

Habbema JD, Wilt TJ, Etzioni R, Nelson HD, Schechter CB, Lawrence WF, Melnikow J, Kuntz KM, Owens DK, Feuer EJ. Habbema JD, et al. Among authors: etzioni r. Ann Intern Med. 2014 Dec 2;161(11):812-8. doi: 10.7326/M14-0845. Ann Intern Med. 2014. PMID: 25437409

2

Asymptomatic incidence and duration of prostate cancer.

Etzioni R, Cha R, Feuer EJ, Davidov O. Etzioni R, et al. Am J Epidemiol. 1998 Oct 15;148(8):775-85. doi: 10.1093/oxfordjournals.aje.a009698. Am J Epidemiol. 1998. PMID: 9786232

3

Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends.

Etzioni R, Penson DF, Legler JM, di Tommaso D, Boer R, Gann PH, Feuer EJ. Etzioni R, et al. J Natl Cancer Inst. 2002 Jul 3;94(13):981-90. doi: 10.1093/jnci/94.13.981. J Natl Cancer Inst. 2002. PMID: 12096083

4

An ecologic study of prostate-specific antigen screening and prostate cancer mortality in nine geographic areas of the United States.

Shaw PA, Etzioni R, Zeliadt SB, Mariotto A, Karnofski K, Penson DF, Weiss NS, Feuer EJ. Shaw PA, et al. Among authors: etzioni r. Am J Epidemiol. 2004 Dec 1;160(11):1059-69. doi: 10.1093/aje/kwh336. Am J Epidemiol. 2004. PMID: 15561985

5

The use of modeling to understand the impact of screening on U.S. mortality: examples from mammography and PSA testing.

Feuer EJ, Etzioni R, Cronin KA, Mariotto A. Feuer EJ, et al. Among authors: etzioni r. Stat Methods Med Res. 2004 Dec;13(6):421-42. doi: 10.1191/0962280204sm376ra. Stat Methods Med Res. 2004. PMID: 15587432

6

Reconstructing PSA testing patterns between black and white men in the US from Medicare claims and the National Health Interview Survey.

Mariotto AB, Etzioni R, Krapcho M, Feuer EJ. Mariotto AB, et al. Among authors: etzioni r. Cancer. 2007 May 1;109(9):1877-86. doi: 10.1002/cncr.22607. Cancer. 2007. PMID: 17372918 Free article.

7

Studies of prostate-cancer mortality: caution advised.

Etzioni R, Feuer E. Etzioni R, et al. Lancet Oncol. 2008 May;9(5):407-9. doi: 10.1016/S1470-2045(08)70112-8. Lancet Oncol. 2008. PMID: 18452850 No abstract available.

8

Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context.

Draisma G, Etzioni R, Tsodikov A, Mariotto A, Wever E, Gulati R, Feuer E, de Koning H. Draisma G, et al. Among authors: etzioni r. J Natl Cancer Inst. 2009 Mar 18;101(6):374-83. doi: 10.1093/jnci/djp001. Epub 2009 Mar 10. J Natl Cancer Inst. 2009. PMID: 19276453 Free PMC article.

9

The prostate cancer conundrum revisited: treatment changes and prostate cancer mortality declines.

Etzioni R, Gulati R, Tsodikov A, Wever EM, Penson DF, Heijnsdijk EA, Katcher J, Draisma G, Feuer EJ, de Koning HJ, Mariotto AB. Etzioni R, et al. Cancer. 2012 Dec 1;118(23):5955-63. doi: 10.1002/cncr.27594. Epub 2012 May 17. Cancer. 2012. PMID: 22605665 Free PMC article.

10

Building better models: if we build them, will policy makers use them? Toward integrating modeling into health care decisions.

Mandelblatt J, Schechter C, Levy D, Zauber A, Chang Y, Etzioni R. Mandelblatt J, et al. Among authors: etzioni r. Med Decis Making. 2012 Sep-Oct;32(5):656-9. doi: 10.1177/0272989X12458978. Med Decis Making. 2012. PMID: 22990079 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

284 results

Search Page